MRNA250404P34000
- 9.09
- +1.20+15.21%
Moderna Newsroom
Moderna Options Spot-On: On April 4th, 144.56K Contracts Were Traded, With 826.61K Open Interest
Moderna (NasdaqGS:MRNA) Takes 17% Hit Amid Global Trade Concerns
RFK Jr. to Reinstate 20% of HHS Staff Laid off After DOGE Errors
Moderna Options Spot-On: On April 3rd, 130.53K Contracts Were Traded, With 815.07K Open Interest
Unusual Options Activity: CCJ, SE and Others Attract Market Bets, CCJ V/OI Ratio Reaches 603.4
RBC Capital Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $32
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna
RBC Cuts Price Target on Moderna to $32 From $40, Keeps Sector Perform Rating
FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy?
Bernstein Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $39
Moderna Options Spot-On: On April 2nd, 58,305 Contracts Were Traded, With 802.5K Open Interest
SA Asks: How Will Changes at FDA Impact Vaccine Makers?
Novavax Bid for Full Approval of COVID Vaccine Stymied by FDA - Report
Moderna Options Spot-On: On April 1st, 173.06K Contracts Were Traded, With 779.03K Open Interest
Tesla, Nvidia, Palantir, CoreWeave, Moderna, LPL Financial: Biggest Stock Movers
Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment With -8% Dip Over Last Month
10 Health Care Stocks With Whale Alerts In Today's Session
Express News | Trump Administration Health Agency Firings Include Staff Overseeing Bird Flu Response
Senior Leaders at HHS Put on Administrative Leave Amid Staff Cuts - Report
Top Midday Stories: Ford US Sales Fall 1.3% Year Over Year in Q1; Judge Denies Johnson & Johnson Unit's Bankruptcy Plan